![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Volz, Nico B.; Hanna, Diana L.; Stintzing, Sebastian; Zhang, Wu; Yang, Dongyun; Cao, Shu; Ning, Yan; Matsusaka, Satoshi; Sunakawa, Yu; Berger, Martin D.; Cremolini, Chiara; Loupakis, Fotios; Falcone, Alfredo und Lenz, Heinz-Josef
(2020):
Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients.
In: Cancers, Bd. 12, Nr. 10, 2947
Berger, Martin D.; Stintzing, Sebastian; Heinemann, Volker; Cao, Shu; Yang, Dongyun; Sunakawa, Yu; Matsusaka, Satoshi; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Hanna, Diana L.; Soni, Shivani; Puccini, Alberto; Zhang, Wu; Cremolini, Chiara; Falcone, Alfredo; Loupakis, Fotios und Lenz, Heinz-Josef
(2018):
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab.
In: Clinical Cancer Research, Bd. 24, Nr. 4: S. 784-793
Berger, Martin D.; Yamauchi, Shinichi; Cao, Shu; Hanna, Diana L.; Sunakawa, Yu; Schirripa, Marta; Matsusaka, Satoshi; Yang, Dongyun; Groshen, Susan; Zhang, Wu; Ning, Yan; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; Lonardi, Sara; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; Loupakis, Fotios; Stintzing, Sebastian und Lenz, Heinz-Josef
(2017):
Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials.
In: European Journal of Cancer, Bd. 77: S. 13-20
Okazaki, Satoshi; Stintzing, Sebastian; Sunakawa, Yu; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Matsusaka, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; West, Jordan D.; Gopez, Roel; Akihito, Tsuji; Ichikawa, Wataru; Heinemann, Volker; DePaolo, R. William und Lenz, Heinz-Josef
(2017):
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
In: International Journal of Cancer, Bd. 141, Nr. 6: S. 1222-1230
Matsusaka, Satoshi; Hanna, Diana L.; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Okazaki, Satoshi; Berger, Martin D.; Miyamato, Yuji; Parekh, Anish; Stintzing, Sebastian; Loupakis, Fotios und Lenz, Heinz-Josef
(2016):
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.
In: Clinical Cancer Research, Bd. 22, Nr. 13: S. 3218-3226
Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D.; Parekh, Anish; West, Jordan D.; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; DePaolo, R. William und Lenz, Heinz-Josef
(2016):
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab.
In: Molecular Cancer therapeutics, Bd. 15, Nr. 7: S. 1740-1745
Berger, Martin D.; Stintzing, Sebastian; Heinemann, Volker; Yang, Dongyun; Sunakawa, Yu; Ning, Yan; Matsusaka, Satoshi; Okazaki, Satoshi; Miyamoto, Yuji; Suenaga, Mitsukuni; West, Jordan David; Zhang, Wu; Petasis, Nicos und Lenz, Heinz-Josef
(2016):
Serum amyloid a (SAA-1) SNP rs12218 to predict outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial.
In: Journal of Clinical Oncology, Bd. 34, Nr. 4